Skip to content

Indoor Air Quality and Respiratory Morbidity in School-Aged Children With BPD

Indoor Air Quality and Respiratory Morbidity in School-Aged Children With BPD

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04107701
Acronym
AeroBPD
Enrollment
165
Registered
2019-09-27
Start date
2019-07-22
Completion date
2025-12-31
Last updated
2026-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchopulmonary Dysplasia, Chronic Lung Disease of Newborn, Environmental Exposure

Keywords

BPD, bronchopulmonary dysplasia, children and environment, environment, bronchopulmonary dysplasia and environment, environment and children, chronic lung disease of newborn, environment and chronic lung disease of the newborn

Brief summary

Investigators want to learn the role of indoor environmental exposures on respiratory symptoms, and, separately, on lung function deficits in school-aged children with bronchopulmonary dysplasia (BPD).

Detailed description

Bronchopulmonary dysplasia (BPD) is the most common respiratory disease affecting children born prematurely and leads to long-term respiratory symptoms and lung function impairment throughout childhood. This study will, evaluate the contribution of indoor sources of respiratory irritants to respiratory health impairment in school-aged children with BPD. State-of-the-art measures of indoor air quality constituents will assess the relationship of nitrogen dioxide (NO2), particulate matter (PM2.5), as well as, concentrations of allergens (mold, mouse, cockroach, pet), endotoxin, air temperature and humidity with concurrently measured respiratory symptoms and lung function in a well-characterized cohort of children with BPD. This research will identify specific harmful components of the indoor environment associated with respiratory morbidity and poor lung function in children with BPD. Investigators will ask the participants to come in for a one time clinic visit for undergoing procedures as well as answering questions regarding health and home environment. During the 1 year of participation there will also be 2 home assessment visits where investigators will take a sample of the home environment as well record home characteristics.

Interventions

None listed

Sponsors

Boston Children's Hospital
Lead SponsorOTHER
National Institute of Environmental Health Sciences (NIEHS)
CollaboratorNIH

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
6 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* children 6-12 yrs old * born \<32 wks gestational age * diagnosis of BPD or \> 28 days of oxygen or respiratory support

Exclusion criteria

* major airway or chest surgery * physical or mental impairment that will prevent from doing spirometry * plans to move out of state within the next 9 months

Design outcomes

Primary

MeasureTime frameDescription
Respiratory Morbidity2 weeksmaximum symptom days in the prior 2 weeks assessed at completion of home sampling visits ( Units: days scale: 0-14 days with symptoms, higher is worse
Lung Function1 yrSpirometry (FEV1 percent predicted) Units: percent Scale: continuous integers, higher is better

Secondary

MeasureTime frameDescription
Lung function1 yearOscillometry (R5-20)
Lung Function1 yearFEV1/FVC units: percent scale: continuous integer, higher is better

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORJonathan Gaffin, MD. MMSc.

Boston Children's Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 7, 2026